1. Home
  2. MAIA vs ZDGE Comparison

MAIA vs ZDGE Comparison

Compare MAIA & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • ZDGE
  • Stock Information
  • Founded
  • MAIA 2018
  • ZDGE 2008
  • Country
  • MAIA United States
  • ZDGE United States
  • Employees
  • MAIA N/A
  • ZDGE N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • MAIA Health Care
  • ZDGE Technology
  • Exchange
  • MAIA Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • MAIA 52.8M
  • ZDGE 50.5M
  • IPO Year
  • MAIA 2022
  • ZDGE N/A
  • Fundamental
  • Price
  • MAIA $2.00
  • ZDGE $2.69
  • Analyst Decision
  • MAIA
  • ZDGE
  • Analyst Count
  • MAIA 0
  • ZDGE 0
  • Target Price
  • MAIA N/A
  • ZDGE N/A
  • AVG Volume (30 Days)
  • MAIA 346.7K
  • ZDGE 211.0K
  • Earning Date
  • MAIA 11-12-2024
  • ZDGE 03-14-2025
  • Dividend Yield
  • MAIA N/A
  • ZDGE N/A
  • EPS Growth
  • MAIA N/A
  • ZDGE N/A
  • EPS
  • MAIA N/A
  • ZDGE N/A
  • Revenue
  • MAIA N/A
  • ZDGE $30,204,000.00
  • Revenue This Year
  • MAIA N/A
  • ZDGE $0.34
  • Revenue Next Year
  • MAIA N/A
  • ZDGE $6.35
  • P/E Ratio
  • MAIA N/A
  • ZDGE N/A
  • Revenue Growth
  • MAIA N/A
  • ZDGE 10.15
  • 52 Week Low
  • MAIA $1.17
  • ZDGE $1.93
  • 52 Week High
  • MAIA $5.99
  • ZDGE $5.18
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 44.72
  • ZDGE 50.88
  • Support Level
  • MAIA $1.97
  • ZDGE $2.42
  • Resistance Level
  • MAIA $2.44
  • ZDGE $2.83
  • Average True Range (ATR)
  • MAIA 0.20
  • ZDGE 0.20
  • MACD
  • MAIA 0.00
  • ZDGE 0.02
  • Stochastic Oscillator
  • MAIA 8.33
  • ZDGE 33.13

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: